Bio-guided optimization of the ultrasound-assisted extraction of compounds from Annona glabra L. leaves using the etiolated wheat coleoptile bioassay by Matsumoto, Sadao et al.
Ultrasonics Sonochemistry 21 (2014) 1578–1584Contents lists available at ScienceDirect
Ultrasonics Sonochemistry
journal homepage: www.elsevier .com/ locate/ul tsonBio-guided optimization of the ultrasound-assisted extraction
of compounds from Annona glabra L. leaves using the etiolated wheat
coleoptile bioassayhttp://dx.doi.org/10.1016/j.ultsonch.2014.01.024
1350-4177/ 2014 Elsevier B.V. All rights reserved.
⇑ Corresponding author. Tel.: +34 956 01 63 60; fax: +34 956 01 64 60.
E-mail address: miguel.palma@uca.es (M. Palma).Sadao Matsumoto a, Rosa M. Varela b, Miguel Palma c,⇑, José M.G. Molinillo b, Inês S. Lima a,
Carmelo G. Barroso c, Francisco A. Macías b
a Department of Botany, Federal University of São Carlos, CP 676, CEP 13565-905 São Carlos, São Paulo, Brazil
b Department of Organic Chemistry, Faculty of Science, Agrifood Campus of International Excellence (ceiA3), University of Cádiz, 11510 Puerto Real, Cádiz, Spain
c Department of Analytical Chemistry, Faculty of Science, Agrifood Campus of International Excellence (ceiA3), University of Cádiz, 11510 Puerto Real, Cádiz, Spaina r t i c l e i n f o
Article history:
Received 22 November 2013
Received in revised form 6 January 2014
Accepted 25 January 2014





Allelopathic activitya b s t r a c t
A bio-guided optimization of the extraction of bioactive components from Annona glabra leaves has been
developed using the etiolated wheat coleoptile bioassay as the control method. The optimization of an
ultrasound-assisted extraction of bioactive compounds using allelopathy results as target values has been
carried out for the first time. A two-level fractional factorial experimental design was applied to optimize
the ultrasound-assisted extraction. The solvent was the extraction variable that had the most marked
effect on the resulting bioactivity of the extracts in the etiolated wheat coleoptile bioassay. Extraction
time, extraction temperature and the size of the ultrasonic probe also influenced the bioactivity of the
extracts. A larger scale extraction was carried out in the next step in the allelopathic study, i.e., the iso-
lation of compounds from the bioactive extract and chemical characterization by spectroscopic tech-
niques, including NMR. Eight compounds were isolated and identified from the active extracts, namely
two steroids (b-sistosterol and stigmasterol), five diterpenes with the kaurane skeleton (ent-kaur-16-
en-19-oic acid, ent-19-methoxy-19-oxokauran-17-oic acid, annoglabasin B, ent-17-hydroxykaur-15-en-
19-oic acid and ent-15b,16b-epoxy-17-hydroxy-kauran-19-oic acid) and the acetogenin asimicin.
The most active compound was annoglabasin B, which showed inhibition with values of 95% at
103 M, 87% at 5  104 M and greater than 70% at 104 M in the etiolated wheat coleoptile bioassay.
 2014 Elsevier B.V. All rights reserved.1. Introduction
Annona glabra is a tropical fruit tree from the family Annona-
ceae and it is in the same genus as the Soursop (Annona muricata)
and Cherimoya (Annona cherimola) [1]. The tree is native to Florida
in the United States, the Caribbean, Central and South America, and
West Africa. A. glabra grows in swamps, is tolerant of saltwater,
and cannot grow in dry soil.
The fruit of A. glabra is edible and it has a pleasant taste and fra-
grant pulp. The spherical fruit is similar in size to an apple or it may
be slightly larger. The consumption of this fruit is usually local and
it has not achieved the popularity of other fruits of the same genus.
The fruit has been reported to have anticancer [2], antimutagenic
[3] and antioxidant properties [4–6].In recent years, the family Annonaceae has been studied in the
search for bioactive compounds. For example, annonaceous ace-
togenins represent a class of compound with a wide variety of bio-
logical activities, including insecticidal behavior and inhibition of
lymphocytic leukemia, carcinoma cells and mitochondrial complex
I [7–9].
A. glabra L. is reported to have parasiticidal and insecticidal
activity and it is used in traditional medicine [10,11]. Bioactive
compounds have been isolated from different parts of this species.
For example, fruit methanol extracts afforded diterpenes that
inhibited mitochondrial cells, cancer cells and HIV reverse trans-
criptase and replication [12,13]. Ethanol extracts from seeds were
found to be potent inhibitors of complex I of the mitochondrial
respiratory chain [14] and were active against Biomphalaria glabra-
ta (mollusc) growth [15]. The stem is also a source of bioactive sub-
stances: hexane extracts presented insecticidal, sporicidal and
cytotoxic activities [16] and also showed larvicidal activity against
Aedes aegypti [10].
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against several tumor cells [11,17]. A number of metabolites were
also isolated from this species, including monoterpenoids, diterpe-
noids, and cyclopeptides among others, but the activities of these
compounds have not been reported to date [18–22]. Despite the
large number of compounds isolated from A. glabra, very little
research has been carried out on the allelopathic activity of its
chemical components.
As mentioned above, A. glabra is a highly problematic invasive
species that typically grows in estuaries and chokes mangroves.
Seedlings cover the edges of mangroves and prevent the germina-
tion of other species. A. glabra affects farms as it grows along fences
and also invades and transforms undisturbed areas [23]. As a result
of these problems, a number of specific programs have been devel-
oped to control this species [13]. Recently, a study of A. glabra
showed the allelopathic potential of leaf extracts against crop pests
and etiolated wheat coleoptiles [24] and these results can be re-
lated to the level of invasiveness. Allelopathic studies carried out
in the laboratory are based on phytotoxicity assays of compounds
that can be extracted, isolated and identified from a plant. These
assays depend on the amount of compound available and are car-
ried out prior to fractionation, isolation and identification. It is
therefore important to obtain extracts in which the concentrations
of the active components are high.
Several advanced extraction techniques can be applied to yield
bioactive extracts and these include ultrasound-assisted extraction
(UAE), supercritical fluid extraction (SFE) and pressurized liquid
extraction (PLE). UAE is a very common extraction technique for
the recovery of active components, mainly due to the mild extrac-
tion conditions applied [25]. Cavitation is the ultrasound mechan-
ical effect that enables greater penetration of solvent into the
sample [26]. Additionally, UAE methods allow the recovery of com-
pounds in shorter times and at lower temperatures. Several exam-
ples have been reported for other techniques in which the
destruction of active molecules occurs due to high extraction tem-
peratures [27–29]. Therefore, the UAE technique is advantageous
for the extraction of heat-sensitive active compounds.
The ultrasound-assisted extraction of oils from chickpea (Cicer
arietinum L.) [30], saponins from ginseng (Panax quinquefolium L.)
[31] and polysaccharides [32] and phenolic compounds such as
corilagin from longan (Dimocarpus longan Lour) pericarp [33] have
been reported. Under the optimal conditions, i.e., 85% acidified eth-
anol with the aid of ultrasonication, a higher extraction yield from
longan pericarp has been obtained in comparison to the conven-
tional extraction approach [33]. Likewise, Zhong and Wang [34]
optimized an ultrasound-assisted extraction process to obtain
polysaccharides from dried longan pulp using a response surface
methodology. The results obtained demonstrate that ultrasound-
assisted extraction is more effective than conventional techniques
for the extraction of bioactive compounds from longan pericarp. A
review of the literature showed that the optimization of ultra-
sound-assisted extraction using allelopathy results as the target
values has not been reported previously.
When developing an extraction process it is important to opti-
mize highly significant factors that affect the extraction in order to
obtain the most active extract. In this respect, it is necessary to car-
ry out an effective bioassay to assess the activity during the extrac-
tion process. The classical approach of changing one variable at a
time and studying the effect of the variable on the response is a
complicated technique that does not allow the evaluation of
interactions between different extraction variables. Experimental
design provides techniques that can be used for both the evalua-
tion of the effects of extraction variables and interactions between
them [35]. The bioassay selected in this study was the etiolated
wheat coleoptile bioassay, which is both rapid (24 h) and sensitive.
Furthermore, this bioassay can be considered as an initialassessment of phytotoxicity in which undifferentiated tissue cells
are used [36–38]. This technique was proposed by Macías et al.
as the first step in the search for potential new herbicides [39].
The aims of the work described here were (i) to define the best
UAE conditions to obtain A. glabra extracts with the highest bioac-
tivity and (ii) to isolate and identify the active compounds from the
most active extract. This study would allow the identification of
the secondary metabolites responsible for the allelopathic activity
of A. glabra.2. Materials and methods
2.1. Sample preparation
Dried A. glabra L. leaves were ground and stored in a refrigera-
tor. Fat and wax were removed from the sample by washing 500 g
of powder with hexane using an ultrasound system (7 mm diame-
ter probe). Ultrasound parameters were fixed as follows: ampli-
tude at 50% and cycle at 0.5 s1 for 15 min without temperature
control. The raffinate was dried in a laboratory oven (40 C) and
stored at 4 C prior to extraction.
2.2. Ultrasound-assisted extractions
A high intensity probe ultrasound generation system of 200 W
and 24 Hz (model UP 200S from Dr. Hielscher GmbH) was used
for the extractions. The amplitude controller allowed the use of
any power level in the range 10–100%. The cycle controller allowed
the use of any cycle in the range 0.1–1.0 (fraction of a second). Two
different probes were available: 2 and 7 mm diameter.
2.3. Etiolated wheat coleoptile bioassay
Wheat seeds (Triticum aestivum L. cv. Duro) were sown in 15 cm
diameter Petri dishes moistened with water and they were grown
in the dark at 25 ± 1 C for 4 days [37]. The roots and caryopses
were removed from the shoots. The latter were placed in a Van
der Weij guillotine and the apical 2 mm were cut off and discarded.
The next 4 mm of the coleoptiles were removed and used for bio-
assays. All manipulations were performed under a green safelight
[38].
Extracts or compounds were dissolved in a buffer solution
(1.1 g L1 of citric acid and 2.9 g L1 of calcium phosphate in dis-
tilled water at pH 5.6) containing 0.5 mL L1 DMSO (dimethyl sulf-
oxide) and 20 g L1 of sucrose. Three extract concentrations (800,
400, 200 ppm) and five concentrations of compounds (103,
5  104, 104, 5  105, 105 M) were used in the bioassay along
with 0 ppm as a negative control and a commercial herbicide
(Logran) as a positive control.
The commercial herbicide Logran, a combination of N-(1,1-
dimethylethyl)-N-ethyl-6-(methylthio)-1,3,5-triazine-2,4-diamine
(terbutryn, 59.4%) and 2-(2-chloroethoxy)-N-{[(4-methoxy-6-
methyl-1,3,5-triazin-2-yl)amino]carbonyl}benzenesulfonamide
(triasulfuron, 0.6%), was used as the internal reference in accor-
dance with a previously reported comparative study [39].
All determinations were run in three replicates, in which each
test tube (replicate) was charged with 2 mL of one of the treat-
ments and 5 coleoptile fragments. Coleoptiles were kept in contact
with the extracts for 24 h. The resulting values for coleoptile
growth in the presence of extract, along with negative control
growth values, are presented as percentages, with positive values
representing stimulation and negative values inhibition versus
the control (0 ppm).
The coleoptiles were measured by digitalization of their images.
Data were statistically analyzed using Welch’s test [40]. Data are
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sents the control, positive values represent stimulation of the stud-
ied parameter and negative values represent inhibition.2.4. Extractions
An initial comparative study was carried out to select the best
solvents. Six different solvents were used under the same extrac-
tion conditions: hexane, chloroform, ethyl acetate, acetone, meth-
anol (MeOH) and water. The extraction conditions were as follows:
2 g of plant sample, 25 mL of solvent, 50% amplitude, 0.5 s1 for cy-
cle and an extraction time of 15 min. Temperature was not con-
trolled during these extractions.2.5. Experimental design for the evaluation of extraction variables
A two-level factorial fractional experimental design was ap-
plied. A total number of 16, rather than the possible 128, sets of
extraction conditions were employed. Seven different extraction
variables were evaluated in two levels (Table 1). In these extrac-
tions 1 g of plant material was used.2.6. General experimental procedures
The purities of the compounds to be tested were determined by
NMR and HPLC and they were found to be >98% pure. 1H and 13C
NMR spectra were recorded using CDCl3 as solvent on a Varian
INOVA spectrometer at 399.99 and 100.577 MHz, respectively.
The resonance of residual chloroform was set to d 7.25. The solvent
peak for 13C was set to d 77.00 (chloroform) and this was used as
the internal reference. UV–vis spectra were obtained using a Var-
ian Cary 50 BIO spectrophotometer with chloroform as the solvent.
Mass spectra (EIMS) were recorded on a Voyager Thermoquest
spectrometer. FTIR spectra were obtained on a Perkin–Elmer Spec-
trum BX FTIR system.
TLC – Alugram Sil G/UV254 plates (0.25 mm thickness) were
used. The plates were analyzed with UV light (254 and 360 nm)
and revealed by heating at 150 C. Three revealers were used:
oleum – sulfuric acid, H2O and acetic acid (1:4:20); anisaldehyde
– anisaldehyde, sulfuric acid, acetic acid, ethanol (25:25:1:450);
and vanillin – vanillin, sulfuric acid, ethanol (1:1:18).
HPLC (High-performance liquid chromatography) – A Hitachi
L-6020 system with a differential refractometer RI-71 detector
was used. Columns: Semi-preparative column (LiChrospher SiO2,
Merck, 7 and 10 lm, 10 and 250 mm column length) with
3 mL min1 as flow rate; Analytical Phenomenex Luna Column
(10 lm Silica (2) 100A) with 1 mL min1 as flow rate.Table 1
Experimental conditions for the 16 extraction in the experimental design and respective a
Experiment T. (C) Volume Time (min) Prob
1 5 25 5 Thin
2 25 25 5 Thin
3 5 50 5 Thin
4 25 50 5 Thin
5 5 25 15 Thin
6 25 25 15 Thin
7 5 50 15 Thin
8 25 50 15 Thin
9 5 25 5 Thic
10 25 25 5 Thic
11 5 50 5 Thic
12 25 50 5 Thic
13 5 25 15 Thic
14 25 25 15 Thic
15 5 50 15 Thic
16 25 50 15 Thic2.7. Compound isolation
For the isolation of compounds a large scale ultrasound-assisted
extraction was carried out. In this process 20 g of plant sample and
500 mL acetone were used in conjunction with the optimized vari-
ables. A total of 1 kg of plant sample was used for extractions, with
8.4 g (DW) of material recovered and used to prepare the sample
for column chromatography.
The extract with the highest bioactivity was selected and its
components were isolated and characterized. Purification by col-
umn chromatography was monitored by TLC and this process
afforded 17 fractions. The eluents used were hexane, hexane/ace-
tone (5%, 10%, 15%, 20%, 40%, 60% and 80%), acetone and methanol.
Fraction 2 (257.3 mg) – This fraction was subjected to HPLC
with a semi-preparative silica gel column. Hexane/ethyl acetate
15% was used as eluent to afford the major component 1,
ent-kaur-16-en-19-oic acid (7.2 mg).
Fraction 3 (622 mg) – This was fractionated on a semi-prepara-
tive silica gel HPLC column, using hexane/ethyl acetate 20% as elu-
ent. b-Sistosterol (2) (5.6 mg) and stigmasterol (3) (1.1 mg) were
isolated.
Chlorophyll was removed from fractions 5–12 using mixtures of
H2O/MeOH as eluent on an RP18 column and dichloromethane
used to elute the chlorophyll from the column. Free chlorophyll
(fraction 8) was further fractionated by semi-preparative HPLC
using hexane/ethyl acetate 25% to yield 18 mg of 4 (ent-19-meth-
oxy-19-oxokauran-17-oic acid).
Fraction 9 provided 6.1 mg of 5, 16a-hydro-19-acetoxy-ent-
kauran-17-oic acid (annoglabasin B).
Fraction 10 was subjected to a semi-preparative HPLC column
with hexane/ethyl acetate 60% to yield 1.3 mg of 6 (ent-17-hydrox-
ykaur-15-en-19-oic acid) and 1.6 mg of 7 (ent-15b,16b-epoxy-17-
hydroxy-kauran-19-oic acid).
Fraction 11 was fractionated on a semi-preparative HPLC col-
umn using hexane/ethyl acetate 40% to give 4.3 mg of annoglaba-
sin B (5).
Fractions 13 and 14 were combined and subjected to column
chromatography using hexane/acetone mixtures of increasing
polarity to give 11 sub-fractions (13A to 13K). Fraction 13F was
fractionated by column chromatography with hexane/ethyl acetate
mixtures from 20% to ethyl acetate 100% as eluent to give 7 new
sub-fractions. The major sub-fraction was submitted to a semi-pre-
parative HPLC column with hexane/ethyl acetate 90% to give com-
pound 8 (asimicin, 36.1 mg).
The bioactivities of the major compounds ent-kaur-16-en-19-
oic acid (1), b-sistosterol (2) ent-19-methoxy-19-oxokauran-17-
oic acid (4), annoglabasin B (5) and asimicin (8) were evaluated
using the wheat coleoptile bioassay.ctivity on coleoptile bioassay (mean values in percentage and standard deviation).
e Solvent Amplitude Cycle 800 ppm
MeOH 30 0.2 56 ± 6.5
Acetone 30 0.8 57 ± 4.5
Acetone 70 0.2 67 ± 2.0
MeOH 70 0.8 26 ± 1.0
Acetone 70 0.8 57 ± 3.0
MeOH 70 0.2 7 ± 5.5
MeOH 30 0.8 19 ± 0.5
Acetone 30 0.2 36 ± 2.0
k MeOH 70 0.8 21 ± 4.5
k Acetone 70 0.2 45 ± 2.0
k Acetone 30 0.8 32 ± 0.5
k MeOH 30 0.2 0 ± 12.5
k Acetone 30 0.2 49 ± 1.0
k MeOH 30 0.8 0 ± 5.5
k MeOH 70 0.2 2 ± 3.0
k Acetone 70 0.8 20 ± 1.5
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The activity data were fitted to a sigmoidal dose–response mod-
el (constant slope) by employing the GraphPad Prism v.4.00 soft-
ware package (GraphPad Software Inc., La Jolla, CA, USA).
Statistical analysis. IC50 values were obtained after the activity
data had been adjusted to concentration (logarithmic scale) to give
a constant slope sigmoidal dose–response curve defined by the
equation
Y ¼ Ymin þ
Ymax  Ymin
1þ 10log IC50X
where X is the logarithm of concentration, Y is the response (activ-
ity) and Ymax and Ymin are the maximum and minimum values of the
response, respectively. Goodness of fit is described by the determi-
nation coefficient (r2).
3. Results and discussion
In an effort to identify the compounds responsible for the bioac-
tivity properties of A. glabra leaves, the ultrasound-assisted extrac-
tion method was optimized using a factorial experimental design
to highlight the most important variables that affect the bioactivity
of the extracts. The etiolated wheat coleoptile bioassay was the
method used to determine the bioactivity. The extraction variables
that showed the highest effects on the bioactivity were subse-
quently studied. Finally, the extraction process was scaled-up to
produce extracts with high levels of bioactivity. The components
were isolated and their chemical structures were elucidated by
spectroscopic techniques to identify the compounds present in
the extracts.
3.1. Optimization of the extraction method
A two-level factorial fractional experimental design was applied
using results from the etiolated wheat coleoptile bioassay as target
values to be maximized. In the experimental design the effects of
different extraction variables on the bioactivity of the resulting ex-
tracts were evaluated. The ranges for the extraction variables were
established to cover the most common values; 5 and 25 C for tem-
perature, 25 and 50 mL for the extraction solvent volume, 5 and
15 min for extraction time, two different ultrasonic probes withFig. 1. Main effects plot for bioactivity ofdifferent diameters [thin (3 mm) and thick (7 mm)], 30% and 70%
ultrasound amplitude, and 0.2 s1 and 0.8 s1 for cycle. All extrac-
tions were carried out in duplicate. However, the resulting dry
weight of the extracts was considered as an initial parameter to as-
sess the reliability of extractions. As a result, extractions that gave
rise to relative differences of greater than 20% in terms of dry
weights were discarded and then repeated prior to analysis of
the bioactivity.
It can be seen from the results in Table 1 that the bioactivities of
the extracts ranged from 0% to 67% and this shows that the
ranges selected for the extraction variables produced large differ-
ences in the recovery of the components responsible for
bioactivity.
Graphical analysis was used to determine the effects of extrac-
tion conditions on the bioactivity values. The main effects of the
extraction variables on the bioactivity are represented in plots
and clear conclusions can be drawn regarding the main experimen-
tal values for a given parameter. It can be seen from Fig. 1 that the
results obtained for the two different solvents show the greatest
differences between the resulting bioactivity values. Experiments
carried out with acetone produced an average inhibition of 45%
whereas experiments carried out with MeOH produced an average
inhibition of 16%. In other words, the change from MeOH to ace-
tone led to a three-fold increase in the inhibitory effect. The other
extraction variables showed less marked effects than extraction
solvent, although the effects were also notable for extraction tem-
perature, extraction time and the size of the ultrasonic probe. As
far as temperature is concerned, higher bioactivities were obtained
on using 5 C than 25 C (38% versus 24% inhibitory activity,
respectively). A lower extraction volume (25 mL) led to higher bio-
activity results than the larger volume (50 mL), with inhibitory ef-
fects of 37% and 25%, respectively. A shorter extraction time
(5 min) also gave rise to better bioactivity results for the extracts
in comparison to the longer extraction time (15 min). Finally, the
thinner ultrasonic probe produced better results than the thicker
probe and resulted in almost double the inhibitory activity
(41% vs 21%).
Optimization of the most influential extraction variables. In
view of the notable effects of temperature and solvent volume, it
was decided to explore different values for these variables that
were not included in the initial experimental design. It was
planned to optimize the extraction after evaluating the kineticsextracts in the experimental design.
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was fixed at 5 min with the thin probe. Four different extraction
volumes (10, 15, 20, 25 mL) were employed at a temperature of
5 C.
In these experiments the temperature was fixed because values
below 5 C led to very little variation in the bioactivity of the ex-
tracts and these results could not easily be differentiated. In addi-
tion, the time required for stabilization of the extraction system
increased. The use of different volumes also produced weak varia-
tions in bioactivity (Table 2) and, as a consequence, the initial sol-
vent volume (25 mL) was chosen because extracts could be filtered
more easily on using 25 mL rather than the lower volume.
The most suitable extraction variables were as follows: 25 mL
acetone, 5 C, 2 mm probe, cycle of 0.2 s1, 30% amplitude for
20 min, using 1 g of plant sample.
Evaluation of extraction kinetics. Extractions were carried out
for different times (1, 2.5, 5, 7.5, 10, 15, 20 min). Longer times than
20 min were not used for operational reasons. Any extraction time
in the range from 7.5 to 20 min was appropriate as they gave high-
er values for the extraction mass (Kruskal–Wallis with Dunn’s
post-test) and better bioactivity results in the coleoptile bioassay
(Table 3).Table 2
Bioactivity results (mean values in percentage and stan-
dard deviation) for extracts obtained using different
solvent volumes.
Volume (mL) Bioactivity (%)
25 62.0 ± 0.0
20 62.0 ± 1.0
15 61.0 ± 2.0
10 63.5 ± 0.5
Table 3
Bioactivity results (mean values in percentage and stan-
dard deviation) for extracts obtained using different
extraction. In the column, same superscript means non-
significant differences (P-level 95%).
Extraction time (min) Bioactivity (%)
1.0 54 ± 0.5a
2.5 56 ± 1.5a
5.0 52 ± 1.5a
7.5 57 ± 6.5ab
10.0 55 ± 1.0ab
15.0 58 ± 8.5ab
20.0 62 ± 2.0b
a,b Values followed by the same letter are indicated as not
significant different (a = 0.05).
Table 4
Bioactivity results (values in percent, relative to controls) for extracts obtained in the
same day (repeatability) and in different days (reproducibility).
Extraction Same day (9
extractions  1 day)
Different days (3













3.4 3.23.2. Analytical properties of the extraction method
Reproducibility and repeatability – 9 extractions were carried
out on the same day in order to determine repeatability and 9
extractions (3 extractions per day on 3 different days) were carried
out to determine reproducibility.
Significant differences were not found in the mean values of
bioactivity results between extractions carried out on the same
day or on different days, according to the Kruskal–Wallis analysis
with Dunn’s post-test P 0.05 (Table 4).
Therefore, the extraction method developed is appropriate to
obtain extracts in a reproducible way in terms of bioactivity, thus
enabling an optimization for future allelopathy studies. It should
also be noted that high bioactivity values (around 60%) were
found for the extracts obtained under the optimized extraction
conditions.3.3. Isolation of active compounds
Having optimized the extraction method, a larger scale extrac-
tion was carried out in order to obtain sufficient extract for the
next step in the allelopathic study, i.e., isolation of compounds
from the bioactive extract. Eight compounds were isolated and
identified from this extract (Fig. 2), two steroids (b-sistosterol (2)
[41] and stigmasterol (3)) [42], five diterpenes with the kaurane
skeleton (ent-kaur-16-en-19 oic acid (1) [20], ent-19-methoxy-
19-oxokauran-17-oic acid (4) [43], annoglabasin B (5) [12],
ent-17-hydroxykaur-15-en-19-oic acid (6) [44,45] and ent-15
b,16 b-epoxy-17-hydroxy-kauran-19-oic acid (7) [46,47]) and the
acetogenin asimicin (8) [48]. The spectroscopic data for these com-
pounds are identical to those reported previously.
The major compounds were ent-kaur-16-en-19-oic acid (1),
b-sistosterol (2), ent-19-methoxy-19-oxokauran-17-oic acid (4),
annoglabasin B (5) and asimicin (8) and these were assayed in
the etiolated wheat coleoptile bioassay (Fig. 3). The compounds
that showed the highest activities were the kauranic diterpenes
1, 4 and 5 and the acetogenin 8. The most active compound, anno-
glabasin B (5), showed strong inhibition, with values of 95% at
103 M, 87% at 5  104 M and more than 70% at 104 M. The
activity decreased with dilution but, even at the lowest concentra-
tions tested, activities of close to 60% at 5  105 M and above
30% at 105 were obtained. The IC50 value for this compound
was 30.4 lM (r2 0.8639). In general, these results are very similar
to those obtained for the commercial herbicide Logran. The only
precedent for the activity of this compound concerns weak activity
against HIV replication in H9 lymphocyte cells [12].Fig. 2. Chemical structures of isolated compounds from Annona glabra leaves.
Fig. 3. Bioactivity results for pure compounds from Annona glabra leaves.
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value of 33.3 lM (r2 0.9892). This compound shows inhibition val-
ues above 65% at the highest concentration tested (103 M) and
close to 60% at 5  104 M. A remarkable feature of this com-
pound is that its activity is retained upon dilution, except at the
lowest concentration (105 M), and the inhibition values remain
above 50%. It has previously been reported that ent-19-meth-
oxy-19-oxokauran-17-oic acid (4) shows cytotoxic selectivity for
PC3 (prostate cancer) cells, albeit with weak potencies [43].
The third most active compound was ent-kaur-16-en-19 oic
acid (1), which has an IC50 of 733.2 lM (r2 0.9174). This compound
also showed inhibition of 60% a 103 M and close to 50% and
40% at 5  104 M and 104 M, respectively. Compound 1 (ent-
kaur-16-en-19-oic acid) was previously described as an active
compound, with MIC values of 10 lg mL1 against the microorgan-
isms Streptococcus sobrinus, Streptococcus mutans, Streptococcus mi-
tis, Streptococcus sanguinis and Lactobacillus casei. This compound
was also proposed as a prototype for the discovery of new effective
anti-infection agents against microorganisms responsible for caries
and periodontal diseases [49]. Compound 1 has also shown anti-
platelet aggregation [50], analgesic [51], antifungal [52,53], smooth
muscle relaxant [54], hypoglycemic [55], cytotoxic and embryo-
toxic [50] effects.
The last compound that showed activity was asimicin (8) and
this gave values of 48% at 103 M and an IC50 of 2013 lM. In con-
trast, b-sitosterol (2) did not show any significant activity. Asimicin
(8) is extremely cytotoxic and shows promising pesticidal activities
against mosquito larvae, spider mites, aphids, the Mexican bean
beetle, striped cucumber beetle, blowfly larvae, and nematodes
[48]. Although asimicin (8) was found to be active in this bioassay,
its activity was lower than that shown by diterpenes from A. glabra
– in particular annoglabasin B (5), which is the most active com-
pound assayed.4. Conclusions
The optimization of the ultrasound extraction process led to the
best conditions to obtain the most active extract. Isolation and
characterization of the components from this extract enabled the
identification of the metabolites that could be responsible for the
activity shown by A. glabra. Of these, the diterpene annoglabasin
B (5) was the most active and this was followed by ent-19-meth-
oxy-19-oxokauran-17-oic acid (4). Both of these compounds have
a carboxylic acid function at position 17 and an ester function on
carbon 19 and these appear to play a role in the defense mecha-
nisms of this species.Acknowledgment
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